R&D Partner Content The Future of Patient-Centric Access is Here! 6th Operationalize: Expanded Access Programs Summit | March 24-26, 2026 | Boston, MA
R&D Partner Content 6th Age-Related Disease Therapeutics Summit Translating Aging Science into a Clinical Reality
Market Access Partner Content Targeted Therapies Partnering & Licensing Summit Asia Accelerate Licensing & Co-Development in Asia: Providing Pharma De-Risked Assets to Fuel Pipelines Faster, & Biotech Access to International Partnersh
R&D Partner Content 7th CNS Drug Delivery Summit Unlocking Safer, More Efficient Delivery to Targeted Brain Regions by Advancing Direct, & Systemic Delivery to the CNS Via TfR1 & Beyond
Market Access Partner Content Measuring Patient Engagement Summit Europe The World’s Only Patient Engagement Measurement Summit is coming to Europe!
R&D Partner Content 4th LNP Immunogenicity & Toxicity Summit Assessing LNP Immunogenicity & Toxicity to Effectively Monitor Clinical Safety & Ensure Regulatory Compliance for Novel Therapeutics & Vaccines
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
